One group developed a VHL pNEN model through homozygous Cre-LoxP deletion of VHL using a glucagon promoter, showing islet dysmorphia and hyperplasia but mostly demonstrating exocrine pancreas tumors [149]. The gene discussed is VHL; the disease is pancreatic exocrine neoplasm.